Kopa Haiku Seborrheic Dermatitis Face Cream
NDC Package 87041-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Kopa Haiku Seborrheic Dermatitis Face Cream (salicylic acid 0.5% and zinc pyrithione 0.25%) cream is a gentle antifungal face cream designed for daily care of sensitive skin prone to seborrheic dermatitis and psoriasis. This formulation utilizes a cream delivery system. Marketed by Trovina Co. Ltd, this product is identified by NDC 87041-005 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
87041-005-01
Package Description
70 g in 1 CARTON
Product Code
87041-005
11-Digit Billing Format
87041000501
RxNorm Crosswalk
  • RxCUI: 2732214 - salicylic acid 0.5 % / zinc pyrithione 0.25 % Topical Cream
  • RxCUI: 2732214 - salicylic acid 5 MG/ML / zinc pyrithione 2.5 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Kopa Haiku Seborrheic Dermatitis Face Cream
Non-Proprietary Name
Salicylic Acid 0.5% And Zinc Pyrithione 0.25%
Substance Name
Salicylic Acid; Zinc Pyrithione
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
A gentle antifungal face cream designed for daily care of sensitive skin prone to seborrheic dermatitis and psoriasis.

Regulatory & Marketing

Labeler Name
Trovina Co. Ltd
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-19-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87041-005-01 identifies a specific commercial package of 70 g in 1 carton of Kopa Haiku Seborrheic Dermatitis Face Cream, a human over the counter drug labeled by Trovina Co. Ltd. This cream is formulated for topical use and contains salicylic acid; zinc pyrithione as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trovina Co. Ltd on January 19, 2026. The current certification is valid through December 31, 2027.

How is this Trovina Co. Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87041000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87041-005-01
11-Digit CMS (5-4-2)
87041-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.